B S Appleby

Summary

Publications

  1. ncbi request reprint Does the presentation of Creutzfeldt-Jakob disease vary by age or presumed etiology? A meta-analysis of the past 10 years
    Brian S Appleby
    The Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA
    J Neuropsychiatry Clin Neurosci 19:428-35. 2007
  2. ncbi request reprint A case of refractoriness to lithium therapy following its discontinuation in a previously responsive patient
    Brian Appleby
    Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Harv Rev Psychiatry 14:330-2. 2006
  3. ncbi request reprint Diagnosis and treatment of depression in Alzheimer's disease: impact on mood and cognition
    B S Appleby
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD, USA
    Panminerva Med 49:139-49. 2007
  4. ncbi request reprint Clozapine for treatment-resistant agitation in dementia
    Hochang B Lee
    Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, 550 N Broadway, Suite 308, Baltimore, MD 21205, USA
    J Geriatr Psychiatry Neurol 20:178-82. 2007

Detail Information

Publications4

  1. ncbi request reprint Does the presentation of Creutzfeldt-Jakob disease vary by age or presumed etiology? A meta-analysis of the past 10 years
    Brian S Appleby
    The Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA
    J Neuropsychiatry Clin Neurosci 19:428-35. 2007
    ....
  2. ncbi request reprint A case of refractoriness to lithium therapy following its discontinuation in a previously responsive patient
    Brian Appleby
    Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Harv Rev Psychiatry 14:330-2. 2006
  3. ncbi request reprint Diagnosis and treatment of depression in Alzheimer's disease: impact on mood and cognition
    B S Appleby
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD, USA
    Panminerva Med 49:139-49. 2007
    ..Successful treatment of dAD has been reported to improve patients' mood and QOL, as well as lower caregiver burden. Further research is needed in therapeutics of dAD to enhance treatment options and effectiveness...
  4. ncbi request reprint Clozapine for treatment-resistant agitation in dementia
    Hochang B Lee
    Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, 550 N Broadway, Suite 308, Baltimore, MD 21205, USA
    J Geriatr Psychiatry Neurol 20:178-82. 2007
    ..Overall, clozapine therapy seemed beneficial in treatment-resistant agitation in dementia patients...